PATH
182
11
14
144
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
7.7%
14 terminated/withdrawn out of 182 trials
91.1%
+4.6% vs industry average
23%
41 trials in Phase 3/4
56%
80 of 144 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (182)
Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine
Role: collaborator
Impact of a Cricket and Black Soldier Fly Larvae-Fortified Cracker on the Gut Microbiome and Iron Status in Malagasy Schoolchildren
Role: collaborator
Low Birthweight and Preterm Infant Feeding Trial and Supportive Care Package: Implementation Research
Role: collaborator
LIFT-UP: Randomized Controlled Trial of Fortification of Human Milk
Role: collaborator
Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia
Role: collaborator
Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh
Role: lead
Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation
Role: lead
Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea
Role: collaborator
Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.
Role: collaborator
FocaL Mass Drug Administration for Vivax Malaria Elimination
Role: collaborator
Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB
Role: lead
Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
Role: collaborator
Infant Malaria Vaccine Schedule Optimization
Role: lead
Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia
Role: lead
Developing a Screening Tool for Primary Immunodeficiency Disease (PID) in Pakistan
Role: lead
Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines
Role: lead
Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds
Role: collaborator
Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa
Role: collaborator
Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia
Role: lead
Challenge Non-Typhoidal Salmonella (CHANTS) Study
Role: collaborator